Cite

HARVARD Citation

    Watanabe, T. et al. (2020). Antitumor activity of cyclin‐dependent kinase inhibitor alsterpaullone in Epstein‐Barr virus‐associated lymphoproliferative disorders. Cancer science. 111 (1), pp. 279-287. [Online]. 
  
Back to record